COMMUNIQUÉS West-GlobeNewswire

Anchiano Therapeutics to Present at the Baird 2019 Global Healthcare Conference
03/09/2019
CAMBRIDGE, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat [...]
XOMA to Present at the H.C. Wainwright 21st Annual Global Investment Conference
03/09/2019
EMERYVILLE, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the H.C. Wainwright 21 [...]
Passage Bio to Present at Morgan Stanley 17th Annual Global Healthcare Conference
03/09/2019
PHILADELPHIA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, today announced that [...]
Apellis Dosed First Patient in Phase 3 Study of APL-2 for Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria
03/09/2019
CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (NASDAQ: APLS) announced today the dosing of the first patient in the Phase 3 clinical study PRINCE (APL2-308), [...]
Pharmacodynamics Evaluation of PhaseBio’s Novel Ticagrelor Reversal Agent Presented at ESC Congress 2019
03/09/2019
Results from three different assays, including VerifyNow® PRUTest®, demonstrate a high degree of correlation MALVERN, Pa. and SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), [...]
CymaBay Therapeutics to Present at Upcoming Investor Conferences in September
03/09/2019
NEWARK, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]
GBT and Sickle Cell Disease Association of America to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference
03/09/2019
Patient Advocates, Healthcare Providers and Policy Makers to Discuss the Latest Advances and Future Trends for Treating Patients with SCD Conference Taking Place During National Sickle Cell Awareness Month Livestream of [...]
SI-BONE, Inc. Announces Wellmark Blue Cross Blue Shield Establishes Positive Coverage for MIS SI Joint Fusion Using iFuse
03/09/2019
Health New England updates MIS SI joint fusion medical policy to cover iFuse exclusively, the 32nd iFuse exclusive commercial coverage policy SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc., ( [...]
Ovid Therapeutics Announces Participation in Two Upcoming Investor Conferences
03/09/2019
NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
Alimera Sciences Launches ILUVIEN® in Germany For Non-Infectious Uveitis Indication
03/09/2019
Second country in Europe where patients now have access to this important new treatment option; marketing to commence immediately ATLANTA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“ [...]
Kaleido Biosciences Presents Data from Clinical Study of KB195 in Patients with Urea Cycle Disorders at Society for the Study of Inborn Errors of Metabolism Annual Symposium
03/09/2019
Data Demonstrate Safety and Tolerability of Microbiome Metabolic Therapy (MMT™) Candidate KB195 and Potential for Effect on Nitrogen Metabolism, a Biomarker of Ammonia Production LEXINGTON, Mass., Sept. 03, 2019 (GLOBE [...]
Tabula Rasa HealthCare Expands Services to PACE in Louisiana
03/09/2019
PACE of Greater New Orleans Selects TRHC to provide Medication Management and Comprehensive Pharmacy Services MOORESTOWN, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC) , a [...]
iCAD to Host Investor Meeting at ASTRO in Chicago
03/09/2019
NASHUA, N.H., Sept. 03, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its executive management [...]
ORYZON to Present at Upcoming International Conferences
03/09/2019
IASLC 20th World Conference on Lung Cancer (WCLC 2019) in Barcelona, Spain 32nd European College of Neuropsychopharmacology (ECNP) Congress in Copenhagen, Denmark Rodman & Renshaw 21st Annual Global Investment [...]
NexoBrid® Highlighted in 39 Presentations at the 18th European Burns Association Congress in Helsinki
03/09/2019
YAVNE, Israel, Sept. 03, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound care management [...]
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference
03/09/2019
FRAMINGHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
Nephros Announces Presentations at Five Upcoming Investor Conferences
03/09/2019
SOUTH ORANGE, NJ, Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical [...]
Strongbridge Biopharma plc to Present at the H.C. Wainwright 21st Annual Global Investment Conference and the Janney Montgomery Scott Healthcare Conference 2019
03/09/2019
DUBLIN, Ireland and TREVOSE, Pa., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Helix BioPharma Corp. and Moffit Cancer Centre to Present at World Molecular Imaging Congress
03/09/2019
Pharmacodynamics of targeted urease and checkpoint blockade using Chemical Exchange Saturation Transfer and 31P-magnetic Resonance Spectroscopy RICHMOND HILL, Ontario, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma [...]

Pages